Brygida Berse, PhD

Adjunct Research Assistant Professor, Pathology & Laboratory Medicine

Brygida Berse
617.638.4500

Biography

Field of study: Molecular Biology/Neuroscience
Expertise: gene expression; signal transduction; cholinergic biology.

Other Positions

  • Graduate Faculty (Primary Mentor of Grad Students), Boston University School of Medicine, Graduate Medical Sciences
  • Bedford VA - Edith Nourse Rogers Memorial VA Hosp

Education

  • University of Warsaw, PhD
  • University of Warsaw, MSc

Publications

  • Published on 3/20/2018

    Lynch JA, Berse B, Rabb M, Mosquin P, Chew R, West SL, Coomer N, Becker D, Kautter J. Underutilization and disparities in access to EGFR testing among Medicare patients with lung cancer from 2010 - 2013. BMC Cancer. 2018 03 20; 18(1):306. PMID: 29554880.

    Read at: PubMed
  • Published on 1/1/2018

    Lynch JA, Rothney MP, Salup RR, Ercole CE, Mathur SC, Duchene DA, Basler JW, Hernandez J, Liss MA, Porter MP, Wright JL, Risk MC, Garzotto M, Efimova O, Barrett L, Berse B, Kemeter MJ, Febbo PG, Dash A. Improving risk stratification among veterans diagnosed with prostate cancer: impact of the 17-gene prostate score assay. Am J Manag Care. 2018 Jan; 24(1 Suppl):S4-S10. PMID: 29337486.

    Read at: PubMed
  • Published on 11/29/2017

    Hull LE, Lynch JA, Berse BB, DuVall SL, Chun DS, Venne VL, Efimova OV, Icardi MS, Kelley MJ. Clinical Impact of 21-Gene Recurrence Score Test Within the Veterans Health Administration: Utilization and Receipt of Guideline-Concordant Care. Clin Breast Cancer. 2018 Apr; 18(2):135-143. PMID: 29306660.

    Read at: PubMed
  • Published on 9/1/2017

    Berse B, Lynch JA, Bowen S, Grosse SD. In Reference to: "Cost and Utility of Thrombophilia Testing". J Hosp Med. 2017 Sep; 12(9):783. PMID: 29056884.

    Read at: PubMed
  • Published on 5/30/2017

    Efimova O, Berse B, Denhalter DW, DuVall SL, Filipski KK, Icardi M, Kelley MJ, Lynch JA. Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration. BMC Med Inform Decis Mak. 2017 05 30; 17(1):71. PMID: 28558785.

    Read at: PubMed
  • Published on 3/23/2017

    Lynch JA, Berse B, Coomer N, Kautter J. 21-Gene recurrence score testing among Medicare beneficiaries with breast cancer in 2010-2013. Genet Med. 2017 Oct; 19(10):1134-1143. PMID: 28333918.

    Read at: PubMed
  • Published on 1/26/2017

    Lynch JA, Berse B, Dotson WD, Khoury MJ, Coomer N, Kautter J. Utilization of genetic tests: analysis of gene-specific billing in Medicare claims data. Genet Med. 2017 Aug; 19(8):890-899. PMID: 28125086.

    Read at: PubMed
  • Published on 1/1/2017

    Chun DS, Berse B, Venne VL, DuVall SL, Filipski KK, Kelley MJ, Meyer LJ, Icardi MS, Lynch JA. BRCA testing within the Department of Veterans Affairs: concordance with clinical practice guidelines. Fam Cancer. 2017 Jan; 16(1):41-49. PMID: 27589855.

    Read at: PubMed
  • Published on 12/7/2016

    Lynch JA, Berse B, Chun D, Rivera D, Filipski KK, Kulich S, Viernes B, DuVall SL, Kelley MJ. Epidermal Growth Factor Receptor Mutational Testing and Erlotinib Treatment Among Veterans Diagnosed With Lung Cancer in the United States Department of Veterans Affairs. Clin Lung Cancer. 2017 Jul; 18(4):401-409. PMID: 28038980.

    Read at: PubMed
  • Published on 10/1/2016

    Lynch J, DuVall SL, Berse B, Whatley A, St Pierre C, Oloruntoba O, Hunt CM. Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013. Mil Med. 2016 Oct; 181(10):1375-1381. PMID: 27753578.

    Read at: PubMed

View 54 more publications: View full profile at BUMC

View all profiles